We are live on
!
Find out more
RP
Rowlandmiller & Partners Portfolio holdings
AUM
$549M
1-Year Est. Return
36.2%
This Fund
S&P 500
This Quarter
Est. Return
+1.63%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$459M
AUM Growth
-$15.1M
(-3.2%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-3.5%
Top 10 Holdings %
Top 10 Hldgs %
38.72%
Holding
186
New
5
Increased
32
Reduced
83
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$1.34M |
| 2 |
Medtronic
MDT
|
+$566K |
| 3 |
Texas Instruments
TXN
|
+$560K |
| 4 |
Brown-Forman Class B
BF.B
|
+$455K |
| 5 |
GE Vernova
GEV
|
+$183K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.38M |
| 2 |
Apple
AAPL
|
+$1.27M |
| 3 |
Qualcomm
QCOM
|
+$1.21M |
| 4 |
Progressive
PGR
|
+$1.15M |
| 5 |
Automatic Data Processing
ADP
|
+$853K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 15% |
| 3 | Healthcare | 13.84% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Staples | 10.08% |
Similar funds
AMG
AI
LWP
WCP
BCM
HIS
AA
V
Rowlandmiller & Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Rowlandmiller & Partners held 186 positions worth $459M, down 3.2% from $474M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rowlandmiller & Partners withdrew a net $16M in Q2 2024, closing 9 positions and reducing 83 holdings. Its most notable exit was Globe Life, an estimated $373K position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Rowlandmiller & Partners opened a new position in lululemon athletica worth $1.2M.
- Rowlandmiller & Partners's largest Q2 2024 buy was lululemon athletica: 4,009 shares worth $1.2M.
- Rowlandmiller & Partners added most to Medtronic in Q2 2024, an estimated $566K increase.
- Rowlandmiller & Partners's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $1.38M.
- Rowlandmiller & Partners fully exited Globe Life in Q2 2024, selling an estimated $373K.
- Rowlandmiller & Partners's ten largest holdings make up 39% of its $459M portfolio in Q2 2024.
- Rowlandmiller & Partners opened 5 new positions and closed 9 in Q2 2024.
- Rowlandmiller & Partners's portfolio value fell 3.2% quarter-over-quarter to $459M.
Based on Rowlandmiller & Partners's 13F filing for Q2 2024, filed 29 Jul 2024.